Wow, simply wow.
I think this is pretty simple. Takeda made a drug. They said it was safe to use except for specific circumstances. Bladder cancer was not one of them. Takeda has liability for selling a defective product.
It is pretty simple really.
As far as I can tell there is no mention of a possible connection between Actos and bladder cancer in the inserts that patients receive until August 2011. A tentative link was established in 2002. That should have been fully disclosed to both doctors and patients.
No matter what you think of people with type 2 diabetes, they have a right to make an informed choice.
It seems to me that with Actos sales nearing 5 Billion annually and being around 26% of Takeda's bottom line they had / have a huge incentive to NOT disclose the information.
Never take pity on pharmaceutical companies, theoretically they are made up of pretty smart people. They should have known to disclose the information.
Actually if you think about it, its pretty cold blooded to know that a product you are selling is harming people but you continue to sell it anyway.